Clinical Trial Update: Recombinant Human Endostatin Continued Pumping Into Vein Combining With CCRT in Unresectable Stage III NSCLC [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating recombinant human endostatin given by continuous infusion with concurrent chemoradiotherapy in unresectable stage III non-sm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Recombinant human endostatin (recombinant human endostatin)

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Stage III Non-small-Cell Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED